Aroa Biosurgery Ltd: Recent Changes in Director’s Interests
Aroa Biosurgery Limited, a health care company specializing in soft tissue regeneration, has recently reported changes in the interests of its directors. The company, based in Auckland, New Zealand, is listed on the ASX All Markets stock exchange and operates globally to improve healing rates and quality in complex wounds and soft tissue reconstructions.
Director’s Interest Notices
John Pinion: A Change of Director’s Interest Notice was filed for John Pinion, with the last notice dated 31 March 2023. The notice was submitted under listing rule 3.19A.2 and section 205G of the Corporations Act.
James McLean: Similarly, a notice was filed for James McLean, with the last notice dated 7 September 2023. This notice also adheres to the same listing rule and section of the Corporations Act.
Brian Ward: The most recent notice pertains to Brian Ward, with the last notice dated 17 June 2025. This notice follows the same regulatory requirements as the previous ones.
Company Overview
Aroa Biosurgery Limited operates in the health care sector, focusing on innovative solutions for soft tissue regeneration. The company’s market capitalization stands at AUD 225,820,000, with a close price of 0.59 AUD as of 23 July 2025. The company’s 52-week high was 0.815 AUD on 8 January 2025, and its 52-week low was 0.35 AUD on 6 April 2025. The price-to-earnings ratio is currently -58.17, reflecting the company’s financial performance.
For more information, Aroa Biosurgery Limited can be reached through their official website at aroabio.com .
Note: The news regarding Pudumjee Paper Products Ltd. and its management system certifications, as well as the submission of newspaper clips for the re-lodgement of transfer requests of physical shares, are unrelated to Aroa Biosurgery Ltd. and have been omitted from this summary.